NBTK.XETRA Invesco NASDAQ Biotech UCITS ETF

ETF Healthcare Equity Invesco Investment Management Limited XETRA Stock Exchange
- EUR
No recent price
Total assets
640M
Expense ratio
0.41%
Dividend yield
0.87%
1-year return
+38.35%
Holdings
1
Since
2014

Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.

What does NBTK.XETRA invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (94.1%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (94.4%)

Asset allocation

  • US stocks 94.1%
  • Non-US stocks 4.7%

Invesco NASDAQ Biotech UCITS ETF performance

Sharpe ratio 1.27
This year
+26.91%
1 year
+38.35%
3 years
+23.26%
5 years
+7.78%

Volatility 16.0% over 1 year and 17.3% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

NBTK.XETRA price

Prices on the chart can differ slightly from the closing prices StockSummer shows.